EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus

Hui Xu iD, Tianyu Liang iD, Zhongwei Wang, Yalu Wei, Zhe Wan, Ruoyu Li, Liangren Zhang iD, Wei Liu iD

Microbiology Spectrum · 04.08.2026 · 14 (8)

DOI: 10.1128/spectrum.00251-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Hui Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Amino Acid Substitution, Antifungal Agents, Aspergillus flavus, Drug Resistance, Fungal. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical management of invasive aspergillosis (IA) is limited by the scarcity of antifungal agents and the emergence and spread of drug resistance, which impairs therapeutic efficacy and poses a significant public health threat. Olorofim, a first-in-class clinical antifungal targeting dihydroorotate dehydrogenase (DHODH), represents a promising therapeutic option for IA. It shows activity against several filamentous fungi, including Aspergillus spp., both in vitro and in vivo . Olorofim-resistant Aspergillus fumigatus isolates, characterized by various amino acid substitutions (with a hotspot at G119), have been generated under laboratory conditions through olorofim exposure. However, the potential olorofim resistance mechanisms in Aspergillus flavus , the second-most common pathogen causing IA globally, remain entirely unexplored. In this study, we revealed that the residue G118 in A. flavus , conserved in many filamentous fungi, is homologous to G119 in A. fumigatus by DHODH amino acid sequence alignment. Using a CRISPR-based point mutation approach, we further confirmed that substitutions at the DHODH G118 residue confer acquired olorofim resistance in A. flavus . Additionally, we established a Galleria mellonella infection model and observed that these resistant isolates exhibited no obvious fitness cost, and olorofim treatment was ineffective against infections caused by DHODH G118 mutants. Molecular docking models further indicated that substitutions at the G118 locus may introduce steric hindrance, reducing the binding affinity between olorofim and the DHODH active site and thereby driving resistance. IMPORTANCE Invasive aspergillosis, a life-threatening infection in immunocompromised patients, is increasingly difficult to treat due to limited antifungal options and rising resistance. Olorofim, a novel antifungal targeting dihydroorotate dehydrogenase (DHODH), represents a promising therapy. While resistance in Aspergillus fumigatus has been linked to DHODH G119 mutations, the mechanisms in the globally prevalent pathogen Aspergillus flavus remained unknown. Using CRISPR-based mutagenesis, we demonstrate that amino acid substitutions at G118 confer olorofim resistance, supported by molecular docking showing reduced drug binding. Importantly, olorofim failed to protect larvae infected with resistant mutants in an infection model. These findings provide essential insights for proactively monitoring and managing olorofim resistance in Aspergillus flavus , aiding clinical and public health responses. This study is registered with ClinicalTrials.gov as NCT05101187 and NCT06969703 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acid SubstitutionAntifungal AgentsAspergillus flavusDrug Resistance, FungalFungal ProteinsPyrimidinesPyrrolesAnimalsHumansAmino Acid SequenceAspergillosisAspergillus fumigatusDihydroorotate DehydrogenaseMicrobial Sensitivity TestsMolecular Docking SimulationOxidoreductases Acting on CH-CH Group DonorsAcetamidesPiperazines

Stichwörter der Autor:innen

Aspergillus flavusCRISPR-Cas9molecular dockingolorofimresistance

Substanzen

Antifungal AgentsDihydroorotate DehydrogenaseFungal ProteinsolorofimOxidoreductases Acting on CH-CH Group DonorsPyrimidinesPyrrolesAcetamidesPiperazines

Autor:innen und Institutionen

  • Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
  • National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
  • Research Center for Medical Mycology, Peking University, Beijing, China.
  • Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.

ORCID-Profile: Hui Xu, Tianyu Liang, Liangren Zhang, Wei Liu

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC

Zitieren

APA

Xu, H., Liang, T., Wang, Z., Wei, Y., Wan, Z., Li, R., Zhang, L., & Liu, W. (2026). Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.00251-26

Vancouver

Xu H, Liang T, Wang Z, Wei Y, Wan Z, Li R, et al. Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.00251-26

BibTeX
@article{Xu2026,
  author = {Xu, Hui and Liang, Tianyu and Wang, Zhongwei and Wei, Yalu and Wan, Zhe and Li, Ruoyu and Zhang, Liangren and Liu, Wei},
  title = {Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1128/spectrum.00251-26}
}
Kostenlos starten →